Gerresheimer at DCAT Week 2026: Comprehensive Solutions for Pharma Supply Chains
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech, and cosmetics industries, will participate in DCAT Week 2026 from March 23–26 at the Lotte New York Palace, New York City.
Gerresheimer supports pharmaceutical and biotech companies from early development through commercial supply with its broad portfolio of primary packaging, closures, accessories, high-value solutions, and drug delivery systems. The company offers glass and plastic containment solutions, as well as advanced drug delivery technologies, across all business units.
High-Value Solutions for Complex Therapies
A particular focus lies on High-Value Solutions for injectables and biologics, including ready-to-fill (RTF/RTU) platforms and drug delivery devices that support self-administration and home care trends. These solutions enhance product stability, streamline fill-finish processes, reduce the total cost of ownership, and improve patient convenience and adherence.
Global Manufacturing and Supply Chain Expertise
Gerresheimer combines deep application know-how with scalable manufacturing capacity across specialized production sites worldwide. Recent investments in state-of-the-art facilities underscore the company’s commitment to meeting the growing demands of the pharmaceutical industry, from clinical trials to commercial-scale production.
Trusted Partner Across the Pharma Ecosystem
DCAT Week provides the perfect opportunity for Gerresheimer’s senior leadership to connect with procurement, technical operations, and development decision-makers from leading pharmaceutical companies, showcasing integrated solutions from containment to final delivery.
For more information, visit www.gerresheimer.com
